Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

NCT04274049 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Arterial Occlusive Disease
Ischemia
Ulcers
Peripheral Vascular Disease

Interventions

GENETIC: NL003
OTHER: Normal Saline

Sponsor

Beijing Northland Biotech. Co., Ltd.